MedPath

Evaluation of the Efficacy of Growth Hormone on Healing of Periapical Pathosis

Not Applicable
Active, not recruiting
Conditions
Periapical Diseases
Growth Hormone
Non Surgical Debulking
Interventions
Procedure: Non surgical debulking of periapical tissues
Procedure: Growth hormone application
Procedure: Root canal treatment
Procedure: Non surgical debulking of periapical tissues with growth hormone application
Registration Number
NCT06433375
Lead Sponsor
Al-Azhar University
Brief Summary

This study aimed to evaluate the effect of growth hormone and non-surgical debulking of periapical tissues on healing of periapical pathosis

Detailed Description

Out of ninety patients, forty-eight healthy male patients aged 18 to 40 years old were selected from outpatients attending the Endodontic Clinic of the Faculty of Dental Medicine, Al-Azhar University Boys, Cairo, Egypt, to be included in this study. The selected patients have no medical contraindications for oral surgical procedures (Scores1-2) according to the classification of the American Society of Anesthesiologists (ASA)(8). Maxillary permanent incisor teeth were selected according to specific inclusion criteria based on preoperative assessment of the patients.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
48
Inclusion Criteria
  • Necrotic teeth with apical periodontitis.
  • Teeth presented with normal pocket depth ranges from 1 to 3mm, up to grade II tooth mobility.
  • Teeth with mature apices, root canal curvature between (0-10º) according to Schneider(9) and radii of curvature between 2 to 5 mm according to Pruett would be included in the study(10).
  • Teeth with estimated working length of 20mm(±2mm) from the incisal edge as a reference point provided that the crown/root ratio was not compromised.
  • Non-critical sized periapical lesion related only to one tooth of a 2 to 4mm diameter and score 3 when evaluated using the Cone Beam Computed Tomography Periapical Index Score (CBCTPAI)(11) , Table (1) presents the scoring scale of CBCT-PAI.
  • Teeth located in anatomic areas in which enucleation of the periapical tissues may jeopardize nearby structures, such as the incisive foramen or nasal cavity should be at least 2 mm away from these structures.
Exclusion Criteria
  • Necrotic teeth with related periapical swelling or sinus tract.
  • Teeth with previous root canal fillings and /or indirect coronal restoration.
  • Teeth with abnormal root canal anatomy.
  • Non-restorable teeth due to insufficient coronal tooth structure.
  • Teeth with periodontal disease.
  • Teeth with grade III mobility.
  • Teeth with clinical evidence of a missing buccal bony plate over the periapical defect.
  • Traumatized teeth with suspected root cracks, fractures, intrusive and extrusive injuries, previously avulsed or lateral luxation injuries.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non surgical debulking groupNon surgical debulking of periapical tissuesTeeth undergo non-surgical debulking of periapical tissues.
Growth hormone groupGrowth hormone applicationTeeth undergoes Growth Hormone application.
Non surgical debulking groupNon surgical debulking of periapical tissues with growth hormone applicationTeeth undergo non-surgical debulking of periapical tissues.
Growth hormone groupNon surgical debulking of periapical tissues with growth hormone applicationTeeth undergoes Growth Hormone application.
Non surgical Debulking & Growth hormone groupNon surgical debulking of periapical tissues with growth hormone applicationTeeth undergo non-surgical debulking of periapical tissues with Growth Hormone application.
Control groupRoot canal treatmentTeeth undergo conventional root canal treatment without any additional intervention
Primary Outcome Measures
NameTimeMethod
Post operative CBCT scan12 months

Evaluation of non surgical root canal tratment healing according to CBCTPAI

Secondary Outcome Measures
NameTimeMethod
Post operative pain assesment120 hours

The postoperative pain assessment was done after the second visit, using the modified verbal descriptor scale (VDS) as follow The VDS consist of a scoring system translated into an Arabic, describes a list of adjectives describing the different level of pain including, no pain (score 0 -1), mild pain (score 2-3), moderate pain (score 4 -5), strong pain (score 6 - 7), severe pain (score 8 - 9), worst pain (score 10).

Trial Locations

Locations (1)

Al Azhar University

🇪🇬

Cairo, Nasr City, Egypt

© Copyright 2025. All Rights Reserved by MedPath